Prilenia

Prilenia

Prilenia

Prilenia Therapeutics is a clinical stage biotech startup founded in 2018 with the purpose of improving the lives of patients and their families by developing treatments for neurodegenerative and neurodevelopmental disorders.
Founded
2018
Raised
$62.5M
Follow us
Alexa global traffic share
Latest funding
$62,500,000
Venture capital (Series A) - 2020
Forbion Capital Partners Sectoral Asset Management Morningside Venture Investments +1
Team Size
1–10
Employees
$62,500,000 Venture capital (Series A)
FinSMEs

Prilenia Therapeutics Raises $62.5M in Series A Funding